Injection-site reactions upon Kineret (anakinra) administration: experiences and explanations

Anakinra (Kineret), a recombinant form of human interleukin-1 (IL-1) receptor antagonist, is approved for the treatment of rheumatoid arthritis (RA) in combination with methotrexate. Kineret is self-administered by daily subcutaneous injections in patients with active RA. The mechanism of action of anakinra is to competitively inhibit the local inflammatory effects of IL-1. Kineret is generally safe and well tolerated and the only major treatment-related side effects that appear are skin reactions at the injection site. Due to the relatively short half-life of anakinra, daily injection of the drug is required. This, in combination with the comparably high rates of injection-site reactions (ISRs) associated with the drug, can become a problem for the patient. The present review summarises published data concerning ISRs associated with Kineret and provides some explanations as to their cause. The objective is also to present some clinical experiences of how the ISRs can be managed

Serotonin transporter gene polymorphisms and brain function during emotional distraction from cognitive processing in posttraumatic stress disorder

BACKGROUND: Serotonergic system dysfunction has been implicated in posttraumatic stress disorder (PTSD). Genetic polymorphisms associated with serotonin signaling may predict differences in brain circuitry involved in emotion processing and deficits associated with PTSD. In healthy individuals, common functional polymorphisms in the serotonin transporter gene (SLC6A4) have been shown to modulate amygdala and prefrontal cortex (PFC) activity in response to salient emotional stimuli. Similar patterns of differential neural responses to emotional stimuli have been demonstrated in PTSD but genetic factors influencing these activations have yet to be examined. METHODS: We investigated whether SLC6A4 promoter polymorphisms (5-HTTLPR, rs25531) and several downstream single nucleotide polymorphisms (SNPs) modulated activity of brain regions involved in the cognitive control of emotion in post-9/11 veterans with PTSD. We used functional MRI to examine neural activity in a PTSD group (n = 22) and a trauma-exposed control group (n = 20) in response to trauma-related images presented as task-irrelevant distractors during the active maintenance period of a delayed-response working memory task. Regions of interest were derived by contrasting activation for the most distracting and least distracting conditions across participants. RESULTS: In patients with PTSD, when compared to trauma-exposed controls, rs16965628 (associated with serotonin transporter gene expression) modulated task-related ventrolateral PFC activation and 5-HTTLPR tended to modulate left amygdala activation. Subsequent to combat-related trauma, these SLC6A4 polymorphisms may bias serotonin signaling and the neural circuitry mediating cognitive control of emotion in patients with PTSD. CONCLUSIONS: The SLC6A4 SNP rs16965628 and 5-HTTLPR are associated with a bias in neural responses to traumatic reminders and cognitive control of emotions in patients with PTSD. Functional MRI may help identify intermediate phenotypes and dimensions of PTSD that clarify the functional link between genes and disease phenotype, and also highlight features of PTSD that show more proximal influence of susceptibility genes compared to current clinical categorizations

Production of sulfur from gypsum as an industrial by-product.

[en] Biological sulfate reduction was investigated at the bench and pilot scales in order to determine optimum culture conditions. Efficient strains of sulfate-reducing bacteria (SRB) were selected by classical microbiological methods and by mutagenesis. Improvement factors, including stripping, scale-up, sulfate,and organic substrate concentrations, have been studied in batch bioreactors. Two types of pilot-scale bioreactors have been adopted, the first being completely mixed with free cells and the second having two stages with immobilized cells on a fixed bed. An overall bioconversion capacity of 11 kg/m(3) .d of gypsum and 1.2 kg/m(3) .d of dissolved organic carbon has been achieved in the two-stage bioreactor.info:eu-repo/semantics/publishe

Plasticity, Not Adaptation to Salt Level, Explains Variation Along a Salinity Gradient in a Salt Marsh Perennial

Evolutionary ecologists have long been intrigued by the fact that many plant species can inhabit a broad range of environmental conditions and that plants often exhibit dramatic differences in phenotype across environmental gradients. We investigated responses to salinity treatments in the salt marsh plant Borrichia frutescens to determine if the species is responding to variation in edaphic salt content through phenotypic plasticity or specialized trait response. We grew seedlings from fruits collected in high- and low-salt microhabitats, assigned seedlings to high- and low-salt treatments in a greenhouse, and measured traits related to salt tolerance. All traits were highly plastic in response to salinity. Plants from the two microhabitats did not differ in trait means or respond differently to the treatments. These results suggest that environmental differences between the two microhabitats are not creating genotypes adapted to high and low salt levels. In addition, despite evidence for variation in allozyme markers in this population, there was no significant genotypic variation (family effect) in any of the trait means measured across microhabitats. There was variation in plasticity for only leaf Na and leaf B concentration. The high degree of plasticity for all traits and the lack of differences among microhabitats across the salinity gradient suggest plasticity in many traits may be fixed for this species